期刊文献+

导尿管伴随尿路感染的菌群及其耐药性分析 被引量:3

下载PDF
导出
摘要 目的:了解导尿管伴随尿路感染的菌群分布及对常用抗菌药物的耐药性。方法:回顾性分析1567例留置导尿管患者尿液的细菌学培养情况(分离的病原菌进行Kirby-Bauer琼脂扩散法药敏试验)。结果:分离的病原菌376株,阳性率达24.0%;其中革兰阴性细菌占56.2%;大肠埃希菌和肺炎克雷伯菌产超广谱β-内酰胺酶率分别为59.8%和47.4%;耐甲氧西林金黄色葡萄球菌和耐甲氧西林表皮葡萄球菌的分离率分别达到54.7%和88.2%。结论:留置导尿管致尿路感染以革兰阴性菌为主,出现多重耐药;应根据药敏试验结果选用抗菌药物。
出处 《温州医学院学报》 CAS 2008年第6期548-549,共2页 Journal of Wenzhou Medical College
  • 相关文献

参考文献7

  • 1Tambyah PA,Maki DG.Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients[J].Arch Intern Med,2000,160(5):678- 682.
  • 2Tambyah PA, Halvorson KT, Maki DG.A prospective study of pathogenesis of catheter-associated urinary tract infections[J]. Mayo Clin Proc,1999,74(2):131-136.
  • 3Alcantar Curiel D,Tinoco JC, Gayosso C,et al.Nosocomial bacteremia and urinary tract infections caused by extendedspectrum beta -lactamase-producing Klebsiella with plasmids carrying both SHV-5 and TLA-1 genes[J].Clin Infect Dis, 2004,38(8):1067-1074.
  • 4Gupta A.Hospital-acquired infections in the neonatal intensive care unit-Klebsiella pneumoniae[J].Semin Perinatol, 2002,26(5):340-345.
  • 5National committee for clinical laboratory standards.Performance standards for antimicrobial susceptibility testing: tenth informational supplement( aerobic dilution) [S].NCCLS, 2005, M100-514.
  • 6Kim MN, Pai CH,Woo JH,et al.Vancomycin-intermediate staphylococcus aureus in Korea[J].J Clin Microbiol,2000 ,38 (10):3879-3881.
  • 7Muratani T,Matsumoto T.Urinary tract infection caused by fluoroquinolone- and cephem-resistant Enterobacteriaceae[J]. Int J Antimicrob Agents,2006,28:S 10-S 13.

同被引文献42

  • 1葛剑平,岳松龄,胡涛.生物膜细菌耐药性机制的研究近况[J].国外医学(口腔医学分册),2004,31(5):351-352. 被引量:9
  • 2潘玉红,李松森,黄心宏.重症监护病房感染的病原菌及耐药性分析[J].海峡预防医学杂志,2005,11(1):48-49. 被引量:5
  • 3李睿明.抗感染治疗新靶点——细菌生物膜[J].医学与哲学(B),2006,27(4):42-44. 被引量:16
  • 4杨丽娴,林楚芳,马惜珍,林章礼,李光昭,孙红,郑楚玉.导尿管外涂氯霉素预防尿路感染的临床研究[J].中华医院感染学杂志,2006,16(9):1012-1014. 被引量:20
  • 5陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:3465.
  • 6Kerenyi M, Batai R, Juhasz V, et al. Lidocaine/prilocainec ream (EMLA) has an antibacterial effect in vitro[J]. J Hos- pInfect,2008,56 (1) : 75-76.
  • 7Rosenthal VD, Todi SK, Alvarez Moreno C, et al. Impact of a multidimensional infection control strategy on catheter-associ ated urinary tract infection rates in the adult intensive care u- nits of 15 developing countries: findings of the International Nosocomial Infection Control Consortium (INICC)[J]. Springer,2012,40(5) :517-526.
  • 8Ko M, Liu CK,Woung LC,et al. Species and antimicrobial re sistance of uropathogens isolated from patients with urinary catheter[J]. Tohoku J Exp Meal,2008,214(4) :311-319.
  • 9戴坤琦,陈群英,奕利娟.导尿管相关性尿路感染的病原菌分布及耐药性[J].中华医药感染学杂志,2012,22(15):3411-3412.
  • 10谭志军,谢惠芳,唐勇华.导尿管伴随行尿路感染生物被膜阳性菌分布及耐药性分析[J].临床和交验医学杂志,2009,8(8):44-46.

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部